Evidence map›Paper›PMID 37860663›Full record

ArticleChemical science2023

Catalytic olefin metathesis in blood.

Igor Nasibullin, Hiromasa Yoshioka, Akari Mukaimine, Akiko Nakamura, Yuriko Kusakari, Tsung-Che Chang, Katsunori Tanaka

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Igor NasibullinBiofunctional Synthetic Chemistry Laboratory, Cluster for Pioneering Research RIKEN Wako-shi Saitama 351-0198 Japan chang.t.ac@m.titech.ac.jp kotzenori@riken.jp.ORCID https://orcid.org/0000-0001-9456-2167
Hiromasa YoshiokaBiofunctional Synthetic Chemistry Laboratory, Cluster for Pioneering Research RIKEN Wako-shi Saitama 351-0198 Japan chang.t.ac@m.titech.ac.jp kotzenori@riken.jp.ORCID https://orcid.org/0000-0002-9281-9982
Akari MukaimineBiofunctional Synthetic Chemistry Laboratory, Cluster for Pioneering Research RIKEN Wako-shi Saitama 351-0198 Japan chang.t.ac@m.titech.ac.jp kotzenori@riken.jp.
Akiko NakamuraBiofunctional Synthetic Chemistry Laboratory, Cluster for Pioneering Research RIKEN Wako-shi Saitama 351-0198 Japan chang.t.ac@m.titech.ac.jp kotzenori@riken.jp.
Yuriko KusakariBiofunctional Synthetic Chemistry Laboratory, Cluster for Pioneering Research RIKEN Wako-shi Saitama 351-0198 Japan chang.t.ac@m.titech.ac.jp kotzenori@riken.jp.
Tsung-Che ChangBiofunctional Synthetic Chemistry Laboratory, Cluster for Pioneering Research RIKEN Wako-shi Saitama 351-0198 Japan chang.t.ac@m.titech.ac.jp kotzenori@riken.jp.
Katsunori TanakaBiofunctional Synthetic Chemistry Laboratory, Cluster for Pioneering Research RIKEN Wako-shi Saitama 351-0198 Japan chang.t.ac@m.titech.ac.jp kotzenori@riken.jp.ORCID https://orcid.org/0000-0001-6932-4802
Pioneer (Japan) · JPTokyo Institute of Technology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The direct synthesis of drugs

Identifiers

PMID37860663
PMCPMC10583672
OpenAlexW4387109981

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.